Waters (WAT) Q1 FY26 earnings call

Waters Corporation delivered a strong Q1 FY26, driven by double-digit organic growth in its legacy businesses and better-than-expected performance from newly acquired Biosciences and Diagnostic Solutions. The company is executing a 180-day plan to reinvigorate growth in the acquired businesses, focusing on operational improvements and early revenue synergies. Management raised its full-year growth and EPS outlook, expressing confidence in a mid-teens adjusted EPS growth algorithm through the end of the decade.